Clinical trial
Resynchronization for Ambulatory Heart Failure Trial in Patients With Chronic Atrial Fibrillation - Pharmacological Rate Control vs. Pace and Ablate With Conduction System Pacing
NCT06299514 is registered in ClinicalTrials.gov with Habib Khan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Resynchronization for Ambulatory Heart Failure Trial in Patients With Chronic Atrial Fibrillation - Pharmacological Rate Control vs. Pace and Ablate With Conduction System Pacing
- Lead sponsor
- Habib Khan
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 25, 2024
- Completion date
- December 31, 2029
- Enrollment
- 600 (estimated)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
arrhythmia atrial, atrial fibrillation, heart failure, pacemaker